HCN1 and post-traumatic stress disorder: This susceptibility was associated with increased expression of HCN1 in the prefrontal cortex, but not the hippocampus, and administration of a HCN1 antagonist increased fear extinction and reduced PTSD- and depressive-like behavior (Yao et al., 2023).